and Everads Therapy. The preclinical study, conducted at Tel Hashomer’s Goldschleger Eye Institute, was led by Prof. Michael Belkin, Dr. Ifat Sher and Prof. Ygal Rotenstreich. In addition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback